222 related articles for article (PubMed ID: 33502828)
1. Secondary prevention of hepatitis B virus-related hepatocellular carcinoma with current antiviral therapies.
Choi J; Lim YS
Kaohsiung J Med Sci; 2021 Apr; 37(4):262-267. PubMed ID: 33502828
[TBL] [Abstract][Full Text] [Related]
2. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.
Ringelhan M; O'Connor T; Protzer U; Heikenwalder M
J Pathol; 2015 Jan; 235(2):355-67. PubMed ID: 25196558
[TBL] [Abstract][Full Text] [Related]
3. Prevention of hepatocellular carcinoma and its recurrence with anti-hepatitis B viral therapy.
Halegoua-De Marzio D; Hann HW
Minerva Gastroenterol Dietol; 2014 Sep; 60(3):191-200. PubMed ID: 25000955
[TBL] [Abstract][Full Text] [Related]
4. Antiviral therapies for hepatitis B virus-related hepatocellular carcinoma.
Zhang YQ; Guo JS
World J Gastroenterol; 2015 Apr; 21(13):3860-6. PubMed ID: 25852270
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of hepatitis B virus-related hepatocellular carcinoma.
Ishikawa T
World J Gastroenterol; 2010 May; 16(20):2463-7. PubMed ID: 20503445
[TBL] [Abstract][Full Text] [Related]
6. Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma.
Wei Q; Xu X; Ling Q; Zhou B; Zheng SS
Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):251-5. PubMed ID: 23742769
[TBL] [Abstract][Full Text] [Related]
7. Does antiviral therapy for chronic hepatitis B reduce the risk of hepatocellular carcinoma?
Abu-Amara M; Feld JJ
Semin Liver Dis; 2013 May; 33(2):157-66. PubMed ID: 23749672
[TBL] [Abstract][Full Text] [Related]
8. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
Lim SG; Mohammed R; Yuen MF; Kao JH
J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment.
Gil-García AI; Madejón A; Francisco-Recuero I; López-López A; Villafranca E; Romero M; García A; Olveira A; Mena R; Larrubia JR; García-Samaniego J
World J Gastroenterol; 2019 Oct; 25(38):5883-5896. PubMed ID: 31636479
[TBL] [Abstract][Full Text] [Related]
10. Review article: the prevention of hepatitis B-related hepatocellular carcinoma.
Lin CL; Kao JH
Aliment Pharmacol Ther; 2018 Jul; 48(1):5-14. PubMed ID: 29722445
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.
Lin CL; Kao JH
J Biomed Sci; 2008 Mar; 15(2):137-45. PubMed ID: 18058038
[TBL] [Abstract][Full Text] [Related]
12. Prevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Kim BK; Han KH; Ahn SH
Oncology; 2011; 81 Suppl 1():41-9. PubMed ID: 22212935
[TBL] [Abstract][Full Text] [Related]
13. Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?
Lok AS
J Gastroenterol Hepatol; 2011 Feb; 26(2):221-7. PubMed ID: 21070361
[TBL] [Abstract][Full Text] [Related]
14. Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease.
Cho JY; Paik YH; Sohn W; Cho HC; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Gut; 2014 Dec; 63(12):1943-50. PubMed ID: 24615378
[TBL] [Abstract][Full Text] [Related]
15. HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues.
Yip TC; Wong GL; Chan HL; Tse YK; Lam KL; Lui GC; Wong VW
J Hepatol; 2019 Mar; 70(3):361-370. PubMed ID: 30367899
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B: A Multicenter Study.
Kim SU; Seo YS; Lee HA; Kim MN; Lee EJ; Shin HJ; Lee YR; Lee HW; Park JY; Kim DY; Ahn SH; Han KH; Um SH; Tak WY; Kweon YO; Kim BK; Park SY
Cancer Epidemiol Biomarkers Prev; 2020 Apr; 29(4):832-837. PubMed ID: 31988073
[TBL] [Abstract][Full Text] [Related]
17. Treatment of chronic hepatitis B: Evolution over two decades.
Yuen MF; Lai CL
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():138-43. PubMed ID: 21199525
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy.
Jiang XY; Huang B; Huang DP; Wei CS; Zhong WC; Peng DT; Huang FR; Tong GD
World J Gastroenterol; 2021 Mar; 27(11):1101-1116. PubMed ID: 33776376
[TBL] [Abstract][Full Text] [Related]
19. [Effect of chronic hepatitis B virus DNA negative transformation and HBsAg clearance on the occurrence of hepatocellular carcinoma].
Zhou JL; Wang BQ; Shi YW; You H
Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):831-833. PubMed ID: 31941236
[TBL] [Abstract][Full Text] [Related]
20. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.
Liaw YF
Semin Liver Dis; 2005; 25 Suppl 1():40-7. PubMed ID: 16103980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
